A new daily tablet for moderate-to-severe plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests an experimental once-daily tablet for adults with moderate-to-severe plaque psoriasis who haven't had enough relief from standard creams or light therapy. The goal is to see if it can clear skin more effectively than placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had stable plaque psoriasis (the most common type) for at least 6 months.
- Your psoriasis covers at least 10% of your body surface (about the size of 10 palms).
- Your psoriasis is moderate to severe, meaning your doctor has already considered stronger treatments or light therapy.
- If you can become pregnant, you must agree to use effective birth control during the study and for 28 days after.
- You do not have any other skin conditions or infections that could affect the trial results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.